Clinical Trial Update: Evaluating Possible Improvement in Tinnitus Severity After 28 Days Dosing of the Study Drug AUT00063 Compared to Placebo [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating whether 28 days of AUT00063 reduces tinnitus severity compared to placebo. The study by Autifony Therapeutics Limited…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinnitus

Drugs mentioned

• AUT00063

Snippet

Sponsor: Autifony Therapeutics Limited | Conditions: Tinnitus, Subjective | Phase 2 | Status: COMPLETED